MedTrace Logo

Validation of the San Francisco Syncope Rule

NCT00300625 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2018-05-15

No results posted yet for this study

Summary

This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Department who had an episode of syncope (passed out) or near syncope (almost passed out). A rule that considers patients with an abnormal ECG, a complaint of shortness of breath, hematocrit less than 30%, systolic blood pressure less than 90 mm Hg, or a history of congestive heart failure was shown predict with a good degree of accuracy which patients would have an adverse event and require admission.

Conditions

  • Syncope
  • Near Syncope

Interventions

PROCEDURE

Application of the San Francisco Syncope Rule

Sponsors & Collaborators

  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Adrienne J Birnbaum, MD · Albert Einstein College of Medicine

  • E J Gallagher, MD · Montefiore Medical Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00300625 on ClinicalTrials.gov